New ASPS review article ESUN Dec.2010
Posted: Wed Dec 15, 2010 11:47 pm
Electronic Sarcoma Update Newsletter - December 2010, Volume 7, Number 6
Alveolar Soft Part Sarcoma (ASPS)
Drs. Torres and Pollock explain the presentation, diagnosis, treatment and
surveillance of Alveolar Soft Part Sarcoma.
http://bit.ly/7jDv0k
or here:
http://sarcomahelp.org/learning_center/asps.html
The review is written by Keila E. Torres, MD, PhD
Surgical Oncology Fellow in Department of Surgical Oncology
The University of Texas M. D. Anderson Cancer Center in Houston, Texas
and
Raphael E. Pollock, MD, PhD
Professor and Head, Division of Surgery
The University of Texas M. D. Anderson Cancer Center in Houston, Texas
MDACC is one the leading cancer treatment centers and since there are no guide lines for ASPS treatment, this review can be used as an expert opinion if you need a back up for the surgery or brain scan.
The article incorrectly states that cediranib clinical trial is closed for enrollment at the present moment when in fact it keeps enrolling (Dec.2010).
Alveolar Soft Part Sarcoma (ASPS)
Drs. Torres and Pollock explain the presentation, diagnosis, treatment and
surveillance of Alveolar Soft Part Sarcoma.
http://bit.ly/7jDv0k
or here:
http://sarcomahelp.org/learning_center/asps.html
The review is written by Keila E. Torres, MD, PhD
Surgical Oncology Fellow in Department of Surgical Oncology
The University of Texas M. D. Anderson Cancer Center in Houston, Texas
and
Raphael E. Pollock, MD, PhD
Professor and Head, Division of Surgery
The University of Texas M. D. Anderson Cancer Center in Houston, Texas
MDACC is one the leading cancer treatment centers and since there are no guide lines for ASPS treatment, this review can be used as an expert opinion if you need a back up for the surgery or brain scan.
The article incorrectly states that cediranib clinical trial is closed for enrollment at the present moment when in fact it keeps enrolling (Dec.2010).